James Loerop, Chief Business Officer at Aclaris Therapeutics, Inc. (ACRS), sold 8,534 shares at $13.89 ($119K) on 2023-02-08, disclosed to the SEC on 2023-02-10.
Open-market sale of $119k ACRS by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.89 | 4,267 | $59K | 50.0% |
| 2 | $13.89 | 4,267 | $59K | 50.0% |
| Total | $13.89 avg | 8,534 | $119K | 100% |
| Filing → |